Letter: portal vein obstruction – which subset of patients could benefit the most? Authors’ reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|9|910-910

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.9, 2015-05, pp. : 910-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: portal vein obstruction – which subset of patients could benefit the most?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 909-909

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: management of portal vein thromboses in cirrhosis – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 699-699

John Wiley & Sons Inc

Access to resources Recommend Favorite

Authors' Reply to the Letter by Madias Entitled ‘”Bronchogenic Stress Cardiomyopathy”, a subset of Takotsubo Syndrome'

By  

Cardiology, Vol. 131, Iss. 3, 2015-05 ,pp. : 161-161

Karger

Access to resources Recommend Favorite

Letter: infliximab in severe ulcerative colitis – is it useful for all patients? Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1413-1414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction – what about recurrent episodes? – Authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 937-937

John Wiley & Sons Inc

Access to resources Recommend Favorite